The UK government has announced a new initiative to make hormone replacement therapy (HRT) more affordable for women experiencing symptoms of menopause. The move is expected to benefit hundreds of thousands of women across the country.
The cost of the treatment has previously been a significant barrier for many women, with prices varying widely depending on the type of medication and the pharmacy.
Under the new scheme, the government will subsidise the cost of HRT, making it more affordable for women who are experiencing menopause symptoms. The scheme is to be be rolled out from 1 April 2023, with the certificate expected to help around 400 000 women save hundreds of pounds a year, reducing their HRT costs to less than £20 a year.
The move has been welcomed by women's health advocates, who have long called for more affordable access to HRT. Many women have been forced to endure the often-debilitating symptoms of menopause because of the high cost of treatment. The new initiative is expected to improve the quality of life for many women and reduce the financial burden of managing menopause symptoms.
Register now to continue reading
Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:
Limited access to our clinical or professional articles
New content and clinical newsletter updates each month